NEOGEN CHEMICALS quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	250	187	+34.0%
EBITDA	48.2	31.5	+53.1%
EBITDA margin	19.3%	16.9%	+2.4 pts
Profit before tax	23.1	14.2	+62.1%
Net profit	17.1	10.3	+66.8%
EPS	₹6.29	₹3.89	+61.7%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	250	247	220	209	187	203	201	193	180	200	164	162	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	3.9	1.0	2.1	1.9	1.2	0.6	1.1	0.8	1.6	2.2	1.6	1.9
	254	248	222	211	188	203	202	194	182	202	166	164
	180	165	192	153	128	164	152	88.6	102	137	119	70.8
	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−47.0	−28.0	−75.6	−41.4	−26.6	−56.7	−42.2	21.2	−5.4	−25.1	−28.5	16.8
	25.3	20.2	26.0	24.3	19.6	18.3	15.7	14.8	16.0	14.8	16.7	17.6
	20.8	21.5	21.5	19.5	12.7	12.5	13.4	12.8	9.8	9.7	10.5	11.1
	8.2	7.6	6.8	7.3	5.8	6.8	7.1	7.1	6.8	5.9	5.7	5.8
	43.0	45.6	45.7	42.9	33.9	40.6	41.8	34.2	36.8	37.0	36.4	30.6
	231	232	216	205	174	186	187	179	166	179	160	153
	48.2	43.9	31.9	30.0	31.5	36.4	34.6	34.5	30.8	35.8	20.3	25.9
	40.0	36.3	25.1	22.7	25.7	29.6	27.5	27.4	24.0	29.9	14.6	20.1
Profit
	23.1	15.9	5.7	5.1	14.2	17.7	15.2	15.4	15.7	22.5	5.6	10.9
	0.0	0.0	0.0	0.0	0.0	−14.1	0.0	0.0	0.0	0.0	0.0	0.0
	23.1	15.9	5.7	5.1	14.2	3.6	15.2	15.4	15.7	22.5	5.6	10.9
	6.0	6.6	2.6	3.8	4.9	7.1	5.0	4.2	3.6	4.0	3.2	1.6
	0.1	−2.1	−0.6	−2.0	−0.8	−5.9	0.3	0.4	0.7	1.5	1.5	1.4
	6.2	4.5	2.1	1.8	4.0	1.3	5.2	4.5	4.3	5.5	4.6	3.1
	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1
	17.1	11.4	3.7	3.4	10.3	2.4	10.0	11.0	11.5	16.9	1.1	7.9
	16.9	11.4	3.6	3.3	10.2	2.4	9.9	10.9	11.5	16.9	1.0	7.9
	0.2	1.0	0.0	−0.1	−0.1	−0.1	−0.1	−0.1	−0.1	−0.6	−0.2	0.1
	17.3	12.3	3.7	3.3	10.2	2.3	9.9	10.9	11.3	16.4	0.9	8.0
	—	—	3.7	—	—	—	10.0	10.9	11.5	16.9	1.1	—
Per share
	₹6.29	₹4.32	₹1.40	₹1.28	₹3.89	₹0.91	₹3.80	₹4.15	₹4.35	₹6.42	₹0.41	₹3.17
	₹6.29	₹4.32	₹1.40	₹1.28	₹3.89	₹0.91	₹3.80	₹4.15	₹4.35	₹6.42	₹0.41	₹3.17
Other comprehensive income — detail
	0.2	1.0	0.0	−0.1	−0.1	−0.1	—	—	—	—	—	—
	0.3	1.2	0.1	−0.1	−0.1	−0.1	−0.2	—	−0.2	−0.7	−0.3	0.1
	0.1	0.3	0.0	−0.0	−0.0	0.0	—	—	—	—	—	—
	—	—	—	—	—	—	−0.0	0.1	−0.1	−0.2	−0.1	0.0
	−0.0	—	—	—	—	—	—	—	—	—	—	—
	0.0	−0.0	0.0	0.0	0.0	—	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	−0.0	0.0	0.0	—	0.0
	17.1	—	3.7	—	—	—	10.0	10.9	11.5	16.9	0.0	—
Per share — as-filed variants
	₹6.29	₹4.32	₹1.40	₹1.28	₹3.89	₹0.91	₹3.80	₹4.15	₹4.35	₹6.42	₹0.41	₹3.17
	₹6.29	₹4.32	₹1.40	₹1.28	₹3.89	₹0.91	₹3.80	₹4.15	₹4.35	₹6.42	₹0.41	₹3.17
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	117	110	104	97.1	85.0	95.3	92.1	83.5	83.6	87.6	73.5	74.1
	46.6%	44.5%	47.1%	46.5%	45.5%	47.0%	45.7%	43.2%	46.4%	43.9%	44.7%	45.8%
Adjusted (ex-exceptional items) — derived
	23.1	15.9	5.7	5.1	14.2	17.7	15.2	15.4	15.7	22.5	5.6	10.9
	0.0	0.0	0.0	0.0	0.0	−14.1	0.0	0.0	0.0	0.0	0.0	0.0
	17.1	11.4	3.7	3.4	10.3	11.6	10.0	11.0	11.5	16.9	1.1	7.9
	₹6.29	₹4.32	₹1.40	₹1.28	₹3.89	₹4.37	₹3.80	₹4.15	₹4.35	₹6.42	₹0.41	₹3.17

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEOGEN₹2,261.70

NEOGEN CHEMICALS LTD.

· Chemicals

Annual Quarterly₹ CrorePeersTATACHEM AETHER NFL LXCHEM PRIVISCL RAIN RALLIS RCFMcap ₹5,966 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	161.7	164.4	199.7	180.0	193.4	201.4	202.8	186.7	208.7	220.0	246.6	250.3
Other Income	1.9	1.6	2.2	1.6	0.8	1.1	0.6	1.2	1.9	2.1	1.0	3.9
Total Income	163.6	166.0	201.9	181.5	194.2	202.5	203.4	187.9	210.6	222.1	247.5	254.2
Expenses
+ Cost of Materials Consumed	70.8	119.5	137.2	101.8	88.6	151.5	164.2	128.4	153.0	191.9	164.8	180.0
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
+ Changes in Inventories	16.8	-28.5	-25.1	-5.4	21.2	-42.2	-56.7	-26.6	-41.4	-75.6	-28.0	-47.0
+ Employee Benefit Expense	17.6	16.7	14.8	16.0	14.8	15.7	18.3	19.6	24.3	26.0	20.2	25.3
+ Finance Costs	11.1	10.5	9.7	9.8	12.8	13.4	12.5	12.7	19.5	21.5	21.5	20.8
+ Depreciation & Amortisation	5.8	5.7	5.9	6.8	7.1	7.1	6.8	5.8	7.3	6.8	7.6	8.2
+ Other Expenses	30.6	36.4	37.0	36.8	34.2	41.8	40.6	33.9	42.9	45.7	45.6	43.0
Total Expenses	152.7	160.4	179.4	165.8	178.7	187.3	185.7	173.7	205.5	216.5	231.7	231.1
EBITDA	25.9	20.3	35.8	30.8	34.5	34.6	36.4	31.5	30.0	31.9	43.9	48.2
EBIT	20.1	14.6	29.9	24.0	27.4	27.5	29.6	25.7	22.7	25.1	36.3	40.0
Profit
PBT before Exceptional Items	10.9	5.6	22.5	15.7	15.4	15.2	17.7	14.2	5.1	5.7	15.9	23.1
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	-14.1	0.0	0.0	0.0	0.0	0.0
Pretax Income	10.9	5.6	22.5	15.7	15.4	15.2	3.6	14.2	5.1	5.7	15.9	23.1
+ Current Tax	1.6	3.2	4.0	3.6	4.2	5.0	7.1	4.9	3.8	2.6	6.6	6.0
+ Deferred Tax	1.4	1.5	1.5	0.7	0.4	0.3	-5.9	-0.8	-2.0	-0.6	-2.1	0.1
Tax Expense	3.1	4.6	5.5	4.3	4.5	5.2	1.3	4.0	1.8	2.1	4.5	6.2
+ Share of Associates & JVs	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2
Net Income	7.9	1.1	16.9	11.5	11.0	10.0	2.4	10.3	3.4	3.7	11.4	17.1
+ Net Income — Continuing Ops	7.9	1.0	16.9	11.5	10.9	9.9	2.4	10.2	3.3	3.6	11.4	16.9
+ Other Comprehensive Income	0.1	-0.2	-0.6	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.0	1.0	0.2
Total Comprehensive Income	8.0	0.9	16.4	11.3	10.9	9.9	2.3	10.2	3.3	3.7	12.3	17.3
Net Income to Common	—	1.1	16.9	11.5	10.9	10.0	—	—	—	3.7	—	—
Per Share
Basic EPS	3.17	0.41	6.42	4.35	4.15	3.80	0.91	3.89	1.28	1.40	4.32	6.29
Diluted EPS	3.17	0.41	6.42	4.35	4.15	3.80	0.91	3.89	1.28	1.40	4.32	6.29
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-0.1	-0.1	-0.1	0.0	1.0	0.2
+ Items NOT to be Reclassified to P&L	0.1	-0.3	-0.7	-0.2	—	-0.2	-0.1	-0.1	-0.1	0.1	1.2	0.3
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	-0.0	-0.0	0.0	0.3	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-0.1	-0.2	-0.1	0.1	-0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	—	—	—	—	—	—	—	—	—	-0.0
+ Tax on Items to be Reclassified	—	—	—	—	—	—	—	0.0	0.0	0.0	-0.0	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	—	0.0	0.0	-0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	—	0.0	16.9	11.5	10.9	10.0	—	—	—	3.7	—	17.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	3.17	0.41	6.42	4.35	4.15	3.80	0.91	3.89	1.28	1.40	4.32	6.29
Diluted EPS — Continuing Operations	3.17	0.41	6.42	4.35	4.15	3.80	0.91	3.89	1.28	1.40	4.32	6.29
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	74.1	73.5	87.6	83.6	83.5	92.1	95.3	85.0	97.1	103.7	109.8	116.5
Gross Margin %	45.84	44.67	43.86	46.44	43.20	45.72	47.00	45.51	46.54	47.11	44.52	46.55
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	10.9	5.6	22.5	15.7	15.4	15.2	17.7	14.2	5.1	5.7	15.9	23.1
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	-14.1	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	7.9	1.1	16.9	11.5	11.0	10.0	11.6	10.3	3.4	3.7	11.4	17.1
EPS Adj	3.17	0.41	6.42	4.35	4.15	3.80	4.37	3.89	1.28	1.40	4.32	6.29
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	24.9	26.4	26.4	26.4	26.4	26.4	26.4	26.4	26.4	26.4	26.4	27.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

NEOGEN CHEMICALS Q2 FY27 results date

NEOGEN CHEMICALS (NSE: NEOGEN) will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, according to the board-meeting notice it filed on 28 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹17.1 crore, up 66.8% from ₹10.3 crore in Q1 FY26 and up 50.2% from ₹11.4 crore in Q4 FY26. Revenue from operations was ₹250 crore, up 34.0% year on year and up 1.5% from the previous quarter.

Board-meeting notice filed: 28 October 2026
Q2 FY26 results (a year earlier): 8 November 2025
Q1 FY27 results (the latest): 24 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 31 October 2026Saturday · notice filed 28 Oct
Q1 FY27 net profit: ₹17.1 Cr+66.8% vs Q1 FY26+50.2% vs Q4 FY26
Q1 FY27 revenue: ₹250 Cr+34.0% vs Q1 FY26+1.5% vs Q4 FY26
Q1 FY27 operating margin: 16.0%+2.2 pts vs Q1 FY26+1.3 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹3.4 CrRevenue ₹209 Cr
Q1 FY27 EPS (basic): ₹6.29

Questions

When will NEOGEN CHEMICALS announce its Q2 FY27 results?

On 31 October 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 28 October 2026). Last year it reported Q2 FY26 on 8 November 2025.

What will NEOGEN CHEMICALS's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹3.4 crore and revenue from operations ₹209 crore. The latest quarter, Q1 FY27, had a net profit of ₹17.1 crore and revenue of ₹250 crore.

What were NEOGEN CHEMICALS's Q1 FY27 results?

Consolidated net profit was ₹17.1 crore, up 66.8% from ₹10.3 crore in Q1 FY26 and up 50.2% from ₹11.4 crore in Q4 FY26. Revenue from operations was ₹250 crore, up 34.0% year on year and up 1.5% from the previous quarter.

How has NEOGEN CHEMICALS's profit changed over the last four quarters?

Net profit by quarter: ₹3.4 crore in Q2 FY26, ₹3.7 crore in Q3 FY26, ₹11.4 crore in Q4 FY26 and ₹17.1 crore in Q1 FY27. That is ₹35.6 crore over the four quarters, up 6.0% from ₹33.5 crore in the four quarters before. Revenue from operations: ₹209 crore, ₹220 crore, ₹247 crore and ₹250 crore.

What was NEOGEN CHEMICALS's net profit in FY26?

Consolidated net profit was ₹28.8 crore in FY26 (April 2025–March 2026), down 17.5% from ₹34.8 crore in FY25. It was ₹35.7 crore in FY24 and ₹50 crore in FY23: down 42.5% over three years, an average fall of 16.8% a year.

What was NEOGEN CHEMICALS's revenue in FY26?

Revenue from operations was ₹862 crore in FY26 (April 2025–March 2026), up 10.9% from ₹778 crore in FY25. It was ₹691 crore in FY24 and ₹686 crore in FY23: up 25.6% over three years, 7.9% a year on average.

Where do these NEOGEN CHEMICALS figures come from?

From NEOGEN CHEMICALS's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.